{
    "symbol": "FBIO",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-09 21:05:12",
    "content": " Total net revenues increased 3 million or 20% to $18.3 million for the three months period ending June 30, 2022 from 15.3 million for the three month period ended June 30, 2021. Cost of goods sold increased by $0.1 million to $7.6 million for the three month period ended June 30, 2022 from $7.5 million for the same period of the prior year. Selling general and administrative expenses increased by $7.4 million to $15.2 million for the three month period ended June 30, 2022, from $7.8 million for the three month period ended June 30, 2021. Research and development licensing acquired decrease $13.7 million or 100% for the three month period ended June 30, 2022, from the prior period of the same quarter in 2021."
}